Cardiomyocyte mitochondrial respiration is reduced by receptor for advanced glycation end-product signaling in a ceramide-dependent manner

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 309, Issue 1, 2015, Pages H63-H69

  Nelson, Michael B ^a   Swensen, Adam C ^b   Winden, Duane R ^a   Bodine, Jared S ^a   Bikman, Benjamin T ^a   Reynolds, Paul R ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b N243 Eyring Science Center   (United States)

Author keywords

Cardiomyopathy; Ceramide; Cigarette smoke; Mitochondria; Receptor for advanced glycation end products

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CERAMIDE; CIGARETTE SMOKE; THERMOZYMOCIDIN; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; LYSINE; MONOUNSATURATED FATTY ACID; N(6)-CARBOXYMETHYLLYSINE; PASSIVE SMOKING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; HEART LEFT VENTRICLE; HEART MUSCLE CELL; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOKING; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; CELL RESPIRATION; DRUG EFFECTS; GENETICS; HEART MITOCHONDRION; HEART VENTRICLE; IN VITRO STUDY; KNOCKOUT MOUSE; METABOLISM; PASSIVE SMOKING; TRANSGENIC MOUSE;

ANIMALS; CELL RESPIRATION; CERAMIDES; FATTY ACIDS, MONOUNSATURATED; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART VENTRICLES; IN VITRO TECHNIQUES; LYSINE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOBACCO SMOKE POLLUTION;

EID: 84935513713     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00043.2015     Document Type: Article

References (48)

1. Abu El-Asrar AM, Nawaz MI, De Hertogh G, Alam K, Siddiquei MM, Van den Eynde K, Mousa A, Mohammad G, Geboes K, Opdenakker G. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis. Mol Vis 20: 1209–1224, 2014.
2. Bekircan-Kurt CE, Uceyler N, Sommer C. Cutaneous activation of rage in nonsystemic vasculitic and diabetic neuropathy. Muscle Nerve 50: 377–383, 2014.
3. Bikman BT. A role for sphingolipids in the pathophysiology of obesity-induced inflammation. Cell Mol Life Sci 69: 2135–2146, 2012.
4. Bikman BT, Summers SA. Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest 121: 4222–4230, 2011.
5. Bismuth J, Lin P, Yao Q, Chen C. Ceramide: a common pathway for atherosclerosis? Atherosclerosis 196: 497–504, 2008.
6. Bodiga VL, Eda SR, Bodiga S. Advanced glycation end products: role in pathology of diabetic cardiomyopathy. Heart Fail Rev 19: 49–63, 2014.
7. Chawla D, Bansal S, Banerjee BD, Madhu SV, Kalra OP, Tripathi AK. Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications. Microvasc Res 95: 1–6, 2014.
8. Chen M, Curtis TM, Stitt AW. Advanced glycation end products and diabetic retinopathy. Curr Med Chem 20: 3234–3240, 2013.
9. Denis U, Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M. Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress induction. Free Radic Biol Med 33: 236–247, 2002.
10. Ding HS, Yang J, Chen P, Yang J, Bo SQ, Ding JW, Yu QQ. The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis. Gene 527: 389–393, 2013.
11. Duncan JG. Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta 1813: 1351–1359, 2011.
12. Hansen ME, Tippetts TS, Anderson MC, Holub ZE, Moulton ER, Swensen AC, Prince JT, Bikman BT. Insulin increases ceramide synthesis in skeletal muscle. J Diabetes Res 2014: 765784, 2014.
13. Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology 144: 171–185, 2015.
14. Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S, Knotts TA, Shui G, Clegg DJ, Wenk MR, Pagliassotti MJ, Scherer PE, Summers SA. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 121: 1858–1870, 2011.
15. Ma H, Li SY, Xu P, Babcock SA, Dolence EK, Brownlee M, Li J, Ren J. Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med 13: 1751–1764, 2009.
16. Maceyka M, Spiegel S. Sphingolipid metabolites in inflammatory disease. Nature 510: 58–67, 2014.
17. Manigrasso MB, Juranek J, Ramasamy R, Schmidt AM. Unlocking the biology of RAGE in diabetic microvascular complications. Trends Endocrinol Metab 25: 15–22, 2014.
18. Nedić O, Rattan SI, Grune T, Trougakos IP. Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology. Free Radic Res 47, Suppl 1: 28–38, 2013.
19. Nicholl ID, Bucala R. Advanced glycation endproducts and cigarette smoking. Cell Mol Biol (Noisy-le-grand) 44: 1025–1033, 1998.
20. Nicholl ID, Stitt AW, Moore JE, Ritchie AJ, Archer DB, Bucala R. Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 4: 594–601, 1998.
21. Nożyński J, Zakliczyński M, Konecka-Mrowka D, Zielinska T, Zak-liczynska H, Nikiel B, Mlynarczyk-Liszka J, Mrowka A, Zembala-Nozynska E, Pijet M, Rdzanowska K, Lange D, Przybylski R, Zem-bala M. Advanced glycation end product accumulation in the cardiomy-ocytes of heart failure patients with and without diabetes. Ann Transplant 17: 53–61, 2012.
22. Park TS, Hu Y, Noh HL, Drosatos K, Okajima K, Buchanan J, Tuinei J, Homma S, Jiang XC, Abel ED, Goldberg IJ. Ceramide is a cardio-toxin in lipotoxic cardiomyopathy. J Lipid Res 49: 2101–2112, 2008.
23. Park TS, Rosebury W, Kindt EK, Kowala MC, Panek RL. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice. Pharmacol Res 58: 45–51, 2008.
24. Ramasamy R, Schmidt AM. Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure. Curr Heart Fail Rep 9: 107–116, 2012.
25. Reynolds PR, Kasteler SD, Cosio MG, Sturrock A, Huecksteadt T, Hoidal JR. RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L1094–L1101, 2008.
26. Reynolds PR, Kasteler SD, Schmitt RE, Hoidal JR. Receptor for advanced glycation end-products signals through Ras during tobacco smoke-induced pulmonary inflammation. Am J Respir Cell Mol Biol 45: 411–418, 2011.
27. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 279: 37124–37132, 2004.
28. Reynolds PR, Stogsdill JA, Stogsdill MP, Heimann NB. Up-regulation of receptors for advanced glycation end-products by alveolar epithelium influences cytodifferentiation and causes severe lung hypoplasia. Am J Respir Cell Mol Biol 45: 1195–1202, 2011.
29. Rinaldi M, Maes K, De Vleeschauwer S, Thomas D, Verbeken EK, Decramer M, Janssens W, Gayan-Ramirez GN. Long-term nose-only cigarette smoke exposure induces emphysema and mild skeletal muscle dysfunction in mice. Dis Model Mech 5: 333–341, 2012.
30. Robinson AB, Johnson KD, Bennion BG, Reynolds PR. RAGE signaling by alveolar macrophages influences tobacco smoke-induced inflammation. Am J Physiol Lung Cell Mol Physiol 302: L1192–L1199, 2012.
31. Robinson AB, Stogsdill JA, Lewis JB, Wood TT, Reynolds PR. RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease. Front Physiol 3: 301, 2012.
32. Rodriguez-Pascual C, Rodriguez-Justo S, García-Villar E, Narro-Vidal M, Torrente-Carballido M, Paredes-Galan E. Quality of life, characteristics and metabolic control in diabetic geriatric patients. Maturi-tas 69: 343–347, 2011.
33. Sakaguchi M, Murata H, Yamamoto K, Ono T, Sakaguchi Y, Mo-toyama A, Hibino T, Kataoka K, Huh NH. TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLos One 6: e23132, 2011.
34. Schmitt S, Linder M, Ständker L, Hammes HP, Preissner KT. Identification of CML-modified proteins in hemofiltrate of diabetic patients by proteome analysis. Exp Clin Endocrinol Diabetes 116: 26–34, 2008.
35. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28: 367–388, 2010.
36. Smith ME, Tippetts TS, Brassfield ES, Tucker BJ, Ockey A, Swensen AC, Anthonymuthu TS, Washburn TD, Kane DA, Prince JT, Bikman BT. Mitochondrial fission mediates ceramide-induced metabolic disruption in skeletal muscle. Biochem J 456: 427–439, 2013.
37. Stogsdill JA, Stogsdill MP, Porter JL, Hancock JM, Robinson AB, Reynolds PR. Embryonic overexpression of receptors for advanced gly-cation end-products by alveolar epithelium induces an imbalance between proliferation and apoptosis. Am J Respir Cell Mol Biol 47: 60–66, 2012.
38. Stogsdill MP, Stogsdill JA, Bodine BG, Fredrickson AC, Sefcik TL, Wood TT, Kasteler SD, Reynolds PR. Conditional overexpression of receptors for advanced glycation end-products in the adult murine lung causes airspace enlargement and induces inflammation. Am J Respir Cell Mol Biol 49: 128–134, 2013.
39. Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45: 42–72, 2006.
40. Talukder MA, Johnson WM, Varadharaj S, Lian J, Kearns PN, El-Mahdy MA, Liu X, Zweier JL. Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circ Physiol 300: H388–H396, 2011.
41. Thatcher MO, Tippetts TS, Nelson MB, Swensen AC, Winden DR, Hansen ME, Anderson MC, Johnson IE, Porter JP, Reynolds PR, Bikman BT. Ceramides mediate cigarette smoke-induced metabolic disruption in mice. Am J Physiol Endocrinol Metab 307: E919–E927, 2014.
42. Tippetts TS, Winden DR, Swensen AC, Nelson MB, Thatcher MO, Saito RR, Condie TB, Simmons KJ, Judd AM, Reynolds PR, Bikman BT. Cigarette smoke increases cardiomyocyte ceramide accumulation and inhibits mitochondrial respiration. BMC Cardiovasc Disord 14: 165, 2014.
43. Tonstad S, Svendsen M. Premature coronary heart disease, cigarette smoking, and the metabolic syndrome. Am J Cardiol 96: 1681–1685, 2005.
44. Wood TT, Winden DR, Marlor DR, Wright AJ, Jones CM, Chavarria M, Rogers GD, Reynolds PR. Acute secondhand smoke-induced pulmonary inflammation is diminished in RAGE knockout mice. Am J Physiol Lung Cell Mol Physiol 307: L758–L764, 2014.
45. Xue J, Rai V, Singer D, Chabierski S, Xie J, Reverdatto S, Burz DS, Schmidt AM, Hoffmann R, Shekhtman A. Advanced glycation end product recognition by the receptor for AGEs. Structure 19: 722–732, 2011.
46. Xue J, Ray R, Singer D, Böhme D, Burz DS, Rai V, Hoffmann R, Shekhtman A. The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs. Biochemistry 53: 3327–3335, 2014.
47. Zhang QJ, Holland WL, Wilson L, Tanner JM, Kearns D, Cahoon JM, Pettey D, Losee J, Duncan B, Gale D, Kowalski CA, Deeter N, Nichols A, Deesing M, Arrant C, Ruan T, Boehme C, McCamey DR, Rou J, Ambal K, Narra KK, Summers SA, Abel ED, Symons JD. Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes 61: 1848–1859, 2012.
48. Zhou X, Wang B, Zhu L, Hao S. A novel improved therapy strategy for diabetic nephropathy: targeting AGEs. Organogenesis 8: 18–21, 2012.